SCHEMBL1099604

SCHEMBL1099604

COP(=O)(CCN(c1sc2ccccc2c1Br)S(=O)(=O)c1ccccc1)OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.36
NR1I2 O75469 1/20 0.35
KEAP1 Q14145 5/20 0.33
NFE2L2 Q16236 5/20 0.33
MAPK1 P28482 1/20 0.33
PTGS2 P35354 1/20 0.33
RORC P51449 1/20 0.33
LMNA P02545 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
HSD11B1 P28845 1/20 0.32
MMP9 P14780 2/20 0.32
MMP1 P03956 1/20 0.32
MMP13 P45452 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099417 0.86 NR1I2 (0.47) TRPM8NR1I2KEAP1NFE2L2MAPK1
SCHEMBL1097407 0.82 KEAP1 (0.37) TRPM8KEAP1NFE2L2MAPK1PTGS2
SCHEMBL1098503 0.81 TDP1 (0.49) TRPM8NR1I2KEAP1NFE2L2L3MBTL1
SCHEMBL1099122 0.81 TRPM8 (0.37) TRPM8KEAP1NFE2L2PTGS2LMNA
SCHEMBL1098799 0.80 C1R (0.44) TRPM8NR1I2KEAP1NFE2L2MAPK1
SCHEMBL1099972 0.80 TRPM8 (0.37) TRPM8KEAP1NFE2L2PTGS2LMNA
SCHEMBL1098844 0.79 NR1I2 (0.44) TRPM8NR1I2KEAP1NFE2L2PTGS2
SCHEMBL1099718 0.79 TRPM8 (0.38) TRPM8NR1I2KEAP1NFE2L2MAPK1
SCHEMBL27789329 0.79 TRPM8 (0.39) TRPM8NR1I2KEAP1NFE2L2PTGS2
SCHEMBL1098270 0.79 ALOX5 (0.44) TRPM8NR1I2KEAP1NFE2L2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885NR1I2 465/4885KEAP1 2521/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885NR1I2 465/4885KEAP1 2521/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885NR1I2 465/4885KEAP1 2521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.